| Literature DB >> 7649852 |
A M Ainsworth1, M I Chicarelli-Robinson, B R Copp, U Fauth, P J Hylands, J A Holloway, M Latif, G B O'Beirne, N Porter, D V Renno.
Abstract
Xenovulene A, a novel inhibitor of benzodiazepine binding to the GABA-benzodiazepine receptor is produced by submerged fermentation of Acremonium strictum. It was isolated from the mycelium by solvent extraction and purified by chromatography on Sephadex LH-20 and octadecyl silica. The structure of xenovulene A was determined to be a novel oxygenated sesquiterpene containing a humulene moiety by interpretation of various spectroscopic data, especially from 2D NMR experiments. Xenovulene A inhibited binding of the benzodiazepine, flunitrazepam, with an IC50 of 40 nM in an in vitro assay using bovine synaptosome membrane preparations.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7649852 DOI: 10.7164/antibiotics.48.568
Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN: 0021-8820 Impact factor: 2.649